Furthermore, SFN downregulated SOX9 in ductal carcinoma in situ (DCIS) leading to reduced stem-like cell frequency in vitro and tumor growth in vivo [121]. This evidence concerns the gene SOX9 and ductal breast carcinoma in situ.